Retrospective Study of Patients With Severe Aplastic Anemia Who Developed High Risk Clonal Evolution With Chromosome 7 Abnormalities After Immunosuppressive Therapy
CompletedOBSERVATIONAL
Enrollment
38
Participants
Timeline
Start Date
June 15, 2020
Primary Completion Date
April 22, 2021
Study Completion Date
March 15, 2022
Conditions
Severe Aplastic Anemia
Trial Locations (1)
20892
National Heart, Lung and Blood Institute (NHLBI), Bethesda
All Listed Sponsors
lead
National Heart, Lung, and Blood Institute (NHLBI)
NIH
NCT04436367 - Retrospective Study of Patients With Severe Aplastic Anemia Who Developed High Risk Clonal Evolution With Chromosome 7 Abnormalities After Immunosuppressive Therapy | Biotech Hunter | Biotech Hunter